Skip to main content Site Map

Research at National Women's

On this page: 

Research Governance Group (RGG)

Covid -19 Infection in Pregnancy Registry

C*Steroid Study

FIIX study

MaPINO Study 

Research Governance Group (RGG)


The RGG have oversight of all research proposals within Women’s Health and Newborn Services, with the exception of compliance audits

 Purpose of the Research Governance Group (RGG)

  • To support a culture of research excellence in all aspects of women’s and newborn health, at Women’s Health and Newborn Services, Starship Children’s Hospital,
  • To enable research at Women’s Health and Newborn
  • To promote integration of research into the clinical
  • To provide a safe research environment for staff and
  • To coordinate research to avoid duplication and burden on staff and patients and
  • To reflect the values of the

All Research Projects within women’s and newborn health will be reviewed by the RGG and ALSO by the ADHB RRC.

 To find out more about our research, visit the Research page on the Auckland DHB website().

Research governance meetings

Mondays 10am - 11.30am

Dates: 14 February, 07 March, 04 April, 02 May, 30 May, 27 June, 25 July, 22 August, 19 September, 17 October, 14 November, 12 December

Documentation to be considered at a meeting needs to be received one week prior to the meeting date.

Covid -19 Infection in Pregnancy Registry

This national registry was established in 2020 and aims to include all women who have a positive COVID-19 test or who have confirmed or probable COVID-19 disease during pregnancy or within 6 weeks after birth. Women will be included in the registry whether or not they develop symptoms, and it will include women who have an early pregnancy loss. Women who have had COVID-19 and have now completed their pregnancies will also be included.

What are we asking you to do?

GPs, midwives, obstetricians in primary care or hospital clinicians are asked to notify us of all women under their care with confirmed or suspected COVID‐19:

  • With or without symptoms
  • At any time in pregnancy or within 6 weeks postpartum (including early pregnancy loss)

Secure notification link:

Informing women: Women must be advised if their details are forwarded to the COVID‐19 Registry, and provided with an information sheet (attached), available from Women may self‐report using the Registry website if they wish to do so. Women may elect to opt off the Registry Database by notifying Registry staff at or 021 0831 4824.

Approval: This Registry has been reviewed and received ethical approval from the Health and Disability Ethics Committee, reference (20/NTB/81). The Registry has the support of the Ministry of Health, Te Kāhui Oranga ō Nuku, RANZCOG, NZCOM, the Paediatric Society of NZ, NZ Newborn Network, NZ Paediatric Surveillance Unit, National Maternity Monitoring Group, Royal NZ College of GPs.

Contacts. If you would like more information on the COVID-19 in Pregnancy New Zealand Registry, visit, via email to or phone 021 0831 4824.

If you would like one of our team to discuss this further via phone or zoom please do let us know as we would be happy to do so.


Katie Groom, Lynn Sadler, Nicola Austin, Kasey Tawhara (Principal Investigators)

Rebecca Hay (Research midwife), Laura Mackay (Research Co-ordinator)

Associate Professor Katie Groom, maternal fetal medicine subspecialist, University of Auckland, Auckland DHB * Dr Lynn Sadler, perinatal epidemiologist, University of Auckland, Auckland DHB * Associate Professor Nicola Austin, neonatologist, Canterbury DHB, Dr Kasey Tawhara, obstetrics & gynaecology registrar, Lakes DHB. Ngāti Raukawa, Ngāti Porou

C*Steroid Study

Can we safely reduce the risk of breathing problems for newborn babies by giving corticosteroid injections to their mothers before a planned caesarean section?

This trial is underway at Auckland Hospital and Liggins Institute, The University of Auckland. This trial may be suitable for you if you are having a planned caesarean section at 35 – 39+6 weeks of pregnancy. Find our more at the C*STEROID Trial website or contact the team at

FIIX study

The FIIX Study is a clinical trial comparing the two main fertility procedures available through public funding in New Zealand – The Fertility and In Vitro Fertilisation (IVF) and Intra Uterine Insemination (IUI) trial in couples with uneXplained infertility.

Couples with unexplained infertility who have been accepted for publicly funded fertility treatment are suitable to participate.

For more information, visit the FIIX study website()

Maternal Psoriasis and Infant Neurodevelopmental outcomes (MaPINO) Study

‘Do inflammatory conditions, such as psoriasis, influence a child’s development? We have designed a study to research this question and are inviting pregnant women with and without psoriasis to take part. All women will have dedicated surveillance of their psoriasis (and dermatology review if needed), and all children will get a full neurodevelopmental assessment at two years of age (plus a small gift and parking and travel expenses). Women less than 15 weeks pregnant will also have blood tests to look at markers of inflammation.

If you are interested or would like more information, please contact: Ms Susan Law Research Nurse, p. 021 744 958 or email

Visit the MaPINO study page() for more information about participating.